16.00
Precedente Chiudi:
$16.47
Aprire:
$15.9414
Volume 24 ore:
1,118
Relative Volume:
0.12
Capitalizzazione di mercato:
$35.14M
Reddito:
$8.50M
Utile/perdita netta:
$-10.94M
Rapporto P/E:
-2.1136
EPS:
-7.57
Flusso di cassa netto:
$-28.76M
1 W Prestazione:
+24.51%
1M Prestazione:
+8.70%
6M Prestazione:
+31.58%
1 anno Prestazione:
+162.73%
Apollomics Inc Stock (APLM) Company Profile
Compare APLM vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
APLM
Apollomics Inc
|
16.00 | 35.14M | 8.50M | -10.94M | -28.76M | -7.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Apollomics Inc Borsa (APLM) Ultime notizie
APLMW | Apollomics Inc. Warrant Insider Trading - Quiver Quantitative
Is Apollomics (APLMW) dividend sustainable? (Smart Money Exits) 2026-04-29Crowd Sentiment Stocks - Newser
Apollomics (Nasdaq: APLM) slashes 2025 loss amid cost cuts and new vebreltinib deal revenue - Stock Titan
Over 282 subjects enrolled as Apollomics targets 2027 U.S. filing - Stock Titan
How Apollomics Inc. (APLM) Affects Rotational Strategy Timing - Stock Traders Daily
APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report.Gamma Squeeze - Newser
APLM: Strategic restructuring and licensing revenue reduced losses, but liquidity and going concern risks persist - TradingView
Apollomics (NASDAQ: APLM) warns on going concern, defers vebreltinib NDA and writes down asset - Stock Titan
Apollomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
APLM SEC FilingsAPOLLOMICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
APLM Forecast — Price Target — Prediction for 2027 - TradingView
Apollomics Inc. Warrant (APLMW) - Minichart
Apollomics (APLM) Stock: Is It a Smart Investment (Slight Loss) 2026-04-18Crowd Entry Signals - Cổng thông tin điện tử tỉnh Lào Cai
Hong Jung Chen Net Worth (2026) - GuruFocus
Ya Chi Huang Net Worth (2026) - GuruFocus
Peter Kuan How Lin Net Worth (2026) - GuruFocus
Yi Kuei Chen Net Worth (2026) - GuruFocus
Chen Huan Jan Net Worth (2026) - GuruFocus
Hsien Shu Tsai Net Worth (2026) - GuruFocus
Apollomics (APLM) director details RSUs, options and warrants in Form 3/A - Stock Titan
Apollomics (APLM) CFO has shares withheld for RSU tax obligations - Stock Titan
(APLM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
[Form 3/A] Apollomics Inc. Amended Initial Statement of Beneficial Ownership - Stock Titan
Apollomics (APLM) director Jan Chen-Huan reports 1,000 RSUs and 1,000 shares - Stock Titan
Apollomics (APLM) CFO details 20,000 RSUs and 15,900 shares in Form 3/A - Stock Titan
Apollomics (ticker: APLM) CEO details direct and indirect share stakes - Stock Titan
Apollomics (APLM) director discloses 1,000 restricted stock units award - Stock Titan
Apollomics (APLM) COO details RSU grants and Maxpro warrant stakes - Stock Titan
Apollomics (APLM) director Huang Ya-Chi details RSU vesting and share holdings - Stock Titan
Tech Rally: Does Apollomics Inc Equity Warrant have pricing power2026 PreEarnings & Fast Entry Momentum Alerts - baoquankhu1.vn
Market Outlook: Is Apollomics Inc in a consolidation phase2026 Bull vs Bear & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Bear Alert: Can Apollomics Inc stock outperform in a bear marketWeekly Stock Analysis & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Bond Watch: Can Apollomics Inc Equity Warrant expand its profit marginsEarnings Miss & Smart Swing Trading Techniques - baoquankhu1.vn
Aug Wrap: Will Apollomics Inc Equity Warrant outperform the market in YEARJobs Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
Risk Off: Is Apollomics Inc attractive at current valuation2026 Analyst Calls & Long-Term Capital Growth Ideas - baoquankhu1.vn
What happens to Apollomics (APLM) Stock after earnings | Price at $15.10, Up 1.68%Viral Trade Signals - Newser
Apollomics, Inc. (APLM) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Yi-Kuei Chen Discloses Investment at Apollomics Inc. with 5.3% Stake - TradingView
Apollomics (APLM) COO Yi-Kuei Chen discloses 5.3% ownership stake in latest filing - Stock Titan
Aug PostEarnings: Is Apollomics Inc subject to activist investor interestWeekly Trend Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Is Apollomics (APLM) Stock Safe to Buy Now | Price at $15.30, Up 4.44%Community Driven Stock Picks - UBND thành phố Hải Phòng
Growth Review: Is Apollomics Inc subject to activist investor interest2026 Market WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Apollomics (APLM) chair reports 41.8% stake and $2M convertible bridge loan - Stock Titan
APLM Stock Analysis: Apollomics Inc stays at 14.72 amid zero daily price change - Newser
Apollomics secures $2M convertible note from CEO Chen By Investing.com - Investing.com South Africa
Apollomics Inc. Secures $2 Million Bridge Financing to Support Biotechnology Initiatives - geneonline.com
Apollomics secures $2M bridge financing from CEO - MSN
Apollomics, Inc. (APLM) stock price, news, quote and history - Yahoo Finance UK
CEO funds Apollomics (Nasdaq: APLM) with $2M zero-interest convertible note - Stock Titan
Apollomics secures $2M convertible note from CEO Chen - Investing.com
Apollomics Inc. Announces $2.0 Million Bridge Financing - Scott Coop
Apollomics Inc Azioni (APLM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):